BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 19, 2026
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Oct. 12, 2005
View Archived Issues
Alzheimer's Drugs Could Follow New Breakthrough
Read More
Biovitrum Cutting Up To 100 Research Positions
Read More
AIM Wants To Fill Funding Gap For European Biotechs
Read More
Clarification
Read More
Avidex In-Licenses Antigen To Focus On Type I Diabetes
Read More
Other News To Note
Read More
Novexel Begins Phase I Trial, Gathers In Milestone Payment
PARIS - Novexel, a specialty pharmaceutical company, initiated a multidose Phase I trial of NXL 103, an orally administered antibiotic for the treatment of bacterial respiratory infections. (BioWorld International)
Read More
New Study Released Touting Global Benefits Of GM Crops
Read More
